Compositions that suppress the nuclear translocation of NFATc1 and NFATc2
JP2026071348A5Pending Publication Date: 2026-06-19UNIVERSITY OF TOKUSHIMA +2
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- UNIVERSITY OF TOKUSHIMA
- Filing Date
- 2026-02-06
- Publication Date
- 2026-06-19
Smart Images

Figure 00000000_0000_ABST
Abstract
The object of the present invention is to provide a novel composition for inhibiting the nuclear translocation of NFATc1 and NFATc2 for anti-allergic purposes. [Solution] The NFATc1 and NFATc2 nuclear translocation inhibitory composition according to the present invention contains an aqueous extract of Terminalia bellirica fruit as an active ingredient. The term "composition" as used herein includes preparations such as liquid foods, supplements and food additives, food and beverages (excluding plants and animals themselves), food and beverage compositions (including processed food and beverages), pharmaceutical compositions, and other substances that can be ingested by animals (including humans).
Need to check novelty before this filing date? Find Prior Art